
ANXA5 AND VEGFA GENE VARIANTS
IN WOMEN WITH EARLY PREGNANCY LOSSES
FROM NORTH MACEDONIA Terzikj M, Bozhinovski Gj, Branoski A, Dimkovska M, Kubelka-Sabit K, Plaseska-Karanfilska D *Corresponding Author: Corresponding author, Prof. Dijana Plaseska-Karanfilska, MD, PhD.
Research Centre for Genetic Engineering and Biotechnology “Georgi D. Efremov”,
Macedonian Academy of Science and Arts, Skopje, North Macedonia, e-mail: dijana@manu.edu.mk page: 5
|
MATERIALS AND METHODS
Materials
For this study, a total of 380 DNA samples were
observed using a multiplex single-base extension reac-
tion assay. The samples were taken from 190 women
experiencing EPLs, 104 from Macedonian and 86 from
Albanian ethnic backgrounds and the same number of
samples were obtained from women without a history of
pregnancy loss as well as at least one healthy live birth
as control group.
Following a methodology outlined by Noveski et
al., the examined women with EPLs were additionally
selected because no fetal chromosomal abnormalities
were detected in their POCs [32]. Of the total number of
women with pregnancy losses, 81 had single pregnancy
loss (sporadic), and 109 had two or more pregnancy losses (recurrent). Also, from the total number of women with
early pregnancy losses, 151 did not have a previous live
birth, and 39 had.
All participants gave informed consent for participa-
tion in the study. The study was conducted according to
the guidelines of the Declaration of Helsinki and approved
by the Ethics Committee of the Macedonian Academy
of Sciences and Arts (09-1047/6 from 04.05.2016). This
work was financially supported by the project “Molecular
basis of spontaneous abortion” (project number: 08-707)
funded by the Macedonian Academy of Sciences and Arts.
Methods
Blood samples were collected from each participant
and utilized for DNA isolation from leukocytes using the
conventional method involving phenol/chloroform extrac-
tion and ethanol precipitation, as described by Efremov et
al. (1999). All individuals were analyzed for the presence
of 4 different variants in the ANXA5 gene: rs28717001
(c.-210A>C), rs28651243 (c.-184T>C), rs112782763 (c.-
229G>A), rs113588187 (c.-135G>A) and 2 variants in the
VEGFA gene: c.-1154G>A (rs1570360) and c.*237C>T
(rs3025039). Taking inspiration from the methodology
previously employed in our laboratory [33, 34, 35], we de-
signed a multiplex single-base extension method for simul-
taneous detection of the 6 variants utilizing the Multiplex
SNaPshot kit (Multiplex SNaPshot; Applied Biosystems,
Warrington, WA) for the reaction, followed by capillary
electrophoresis on an ABI Prism 3130 Genetic Analyzer
(Applied Biosystems, Foster City, CA).
The PCR primers were designed to function in a mul-
tiplex mix and to produce PCR fragments of 427–550 bp.
Briefly, the PCR amplification reaction contained 2 µL of
100 ng genomic DNA, 1.5 µL of a multiplex mix where each specific forward and reverse oligonucleotide primers
are with a 10 pmol concentration (Table 1), 2 µL 2.5mM
of each deoxyribonucleotide triphosphate (dNTP), 1.5
µL 25mM magnesium chloride, 5 µL GC rich enhancer
and 0.2 µL of 1U Taq polymerase (Hot Fire polymerase;
Solis Biodyne, Tartu, Estonia) in a total volume of 25 µL.
The PCR conditions were as follows: 10 min. initial
denaturation at 95°C, followed by 33 cycles of 1 min at
95°C,1 min at 61°C for the primer annealing and 1 min
at 72°C. The final elongation was set at 72°C for 10 min.
Afterwards, purification was carried out using 1µL of
ExoSAP-IT® (USB, Cleveland, OH) per 2.5 µL of PCR
product. The process included an incubation step at 37°C
for 20 minutes and subsequent inactivation of the enzyme
at 86°C for 20 minutes.
The refined PCR products served as the basis for
identifying the six mutations. In the subsequent single-
base extension reaction, the detection primers (SNaPshot
primers) were aligned adjacent to the single-nucleotide
polymorphism position. Various lengths of poly (dC) tails
were appended to the single-base extension primers (re-
fer to Table 2). The SNaPshot reaction included a 1.5µL
primer mix comprising all 6 single-base extension prim-
ers at 3.5µL of purified PCR products, and 1.5µL of the
SNaPshot Multiplex kit (Applied Biosystems), adding
up to a final volume of 6.5 µL. The cycling profile com-
prised of 25 cycles of 95°C for 10 s, 55°C for 10 s, and
60°C for 30 s. After the reaction, the 5’-phosphophoryl
groups of unincorporated dideoxynucleotide triphosphates
were eliminated by adding 1.0U of shrimp alkaline phos-
phatase (SAP; USB), followed by an incubation step at
37°C for 40 min and at 86°C for 20 min to deactivate the
enzyme. Capillary electrophoresis was conducted using
an ABI PRISM 3130 Genetic Analyzer, and the results
were analyzed usiBiosystems, Foster City, CA). Specifics of the multiplex
PCR and SNaPshot reaction products can be found in
Table 2. Due to the impact of the dye, size, and nucleotide
composition on the mobility shift of DNA fragments, the
reported sizes may deviate by a few bases from the actual
sizes, especially with shorter fragments where the relative
contribution of the dye is more pronounced. Figure 1 dis-
plays a representative electrophoretogram from a patient
heterozygous for all six variants.
The Chi-square test as well as Fisher’s exact test,
were employed to assess the significance of the results
in both the examined and control groups was determined
based on the p-value. A p-value <0.05 was considered
statistically significant.ng Gene Mapper, Version 4.0 (Applied
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|